Completed NA INTERVENTIONAL 1-arm NCT03299036

Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy

Hydrophilic Radiopaque Microsphere With Doxorubicin for Hepatoma Embolization Therapy

Sponsor: National Cheng Kung University

Interventions Taiwan ACE Beads with doxorubicin

Updated 8 times since 2017 Last updated: Oct 18, 2018 Started: Jun 1, 2017 Primary completion: Oct 16, 2018 Completion: Oct 16, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03299036, this NA trial focuses on Cancer of Liver and remains completed. Sponsored by National Cheng Kung University, it has been updated 8 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Dec 2025 — Present [monthly]

Completed NA
Sep 2025 — Dec 2025 [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

▶ Show 3 earlier versions

Nov 2018 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2018 — Nov 2018 [monthly]

Recruiting NA
Oct 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cheng Kung University
National Cheng-Kung University Hospital
The Industrial Technology Research Institute

Data source: National Cheng-Kung University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tainan, Taiwan